Chlamydial biology and its associated virulence blockers

References

• Aberg V, Almqvist F. (2007). Pilicides-small molecules targeting bacterial virulence. Org Biomol Chem, 5, 1827–1834
   PubMed Web of Science ®Google Scholar
• Aiello D, Williams JD, Majgier-Baranowska H, Patel I, Peet NP, Huang J, Lory S, Bowlin TL, Moir DT. (2010). Discovery and characterization of inhibitors of Pseudomonas aeruginosa type III secretion. Antimicrob Agents Chemother, 54, 1988–1999
   PubMed Web of Science ®Google Scholar
• Al-Younes HM, Rudel T, Meyer TF. (1999). Characterization and intracellular trafficking pattern of vacuoles containing Chlamydia pneumoniae in human epithelial cells. Cell Microbiol, 1, 237–247
   PubMedGoogle Scholar
• Andersen AA, Rogers DG. (1998). Resistance to tetracycline and sulfadiazine in swine C. trachomatis isolates. In: Stephens RS, ed. Ninth International Symposium on Human Chlamydial Infection, San Fransico; 313–316
   Google Scholar
• Arevalo-Ferro C, Hentzer M, Reil G, Görg A, Kjelleberg S, Givskov M, Riedel K, Eberl L. (2003). Identification of quorum-sensing regulated proteins in the opportunistic pathogen Pseudomonas aeruginosa by proteomics. Environ Microbiol, 5, 1350–1369
   PubMed Web of Science ®Google Scholar
• Awasthi D, Kumar K, Ojima I. (2011). Therapeutic potential of FtsZ inhibition: a patent perspective. Expert Opin Ther Pat, 21, 657–679
   PubMed Web of Science ®Google Scholar
• Bailey L, Gylfe A, Sundin C, Muschiol S, Elofsson M, Nordström P, Henriques-Normark B, Lugert R, Waldenström A, Wolf-Watz H, Bergström S. (2007). Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle. FEBS Lett, 581, 587–595
   PubMed Web of Science ®Google Scholar
• Balañá ME, Niedergang F, Subtil A, Alcover A, Chavrier P, Dautry-Varsat A. (2005). ARF6 GTPase controls bacterial invasion by actin remodelling. J Cell Sci, 118, 2201–2210
   PubMedGoogle Scholar
• Banin E, Lozinski A, Brady KM, Berenshtein E, Butterfield PW, Moshe M, Chevion M, Greenberg EP, Banin E. (2008). The potential of desferrioxamine-gallium as an anti-Pseudomonas therapeutic agent. Proc Natl Acad Sci USA, 105, 16761–16766
   PubMed Web of Science ®Google Scholar
• Barbour AG, Amano K, Hackstadt T, Perry L, Caldwell HD. (1982). Chlamydia trachomatis has penicillin-binding proteins but not detectable muramic acid. J Bacteriol, 151, 420–428
   PubMedGoogle Scholar
• Bavoil P, Ohlin A, Schachter J. (1984). Role of disulfide bonding in outer membrane structure and permeability in Chlamydia trachomatis. Infect Immun, 44, 479–485
   PubMed Web of Science ®Google Scholar
• Bavoil PM, Hsia RC. (1998). Type III secretion in Chlamydia: a case of déjà vu? Mol Microbiol, 28, 860–862
   PubMedGoogle Scholar
• Beeckman DS, Van Droogenbroeck CM, De Cock BJ, Van Oostveldt P, Vanrompay DC. (2007). Effect of ovotransferrin and lactoferrins on Chlamydophila psittaci adhesion and invasion in HD11 chicken macrophages. Vet Res, 38, 729–739
   PubMedGoogle Scholar
• Beeckman DS, Meesen G, Van Oostveldt P, Vanrompay D. (2009). Digital titration: automated image acquisition and analysis of load and growth of Chlamydophila psittaci. Microsc Res Tech, 72, 398–402
   PubMedGoogle Scholar
• Beeckman DS, Vanrompay DC. (2010a). Biology and intracellular pathogenesis of high or low virulent Chlamydophila psittaci strains in chicken macrophages. Vet Microbiol, 141, 342–353
   PubMed Web of Science ®Google Scholar
• Beeckman DSA, Vanrompay DCG. (2010b). Bacterial Secretion Systems with an Emphasis on the Chlamydial Type III Secretion System. Curr Issues Mol Biol, 12, 17–41
   PubMed Web of Science ®Google Scholar
• Belland RJ, Ouellette SP, Gieffers J, Byrne GI. (2004). Chlamydia pneumoniae and atherosclerosis. Cell Microbiol, 6, 117–127
   PubMedGoogle Scholar
• BelVet-SAC. (2012). BelVet-SAC report 2012. Belgian Veterinary Surveillance of Antimicrobial Consumption. Available at: www.belvetsac.ugent.be
   Google Scholar
• Byrne GI, Moulder JW. (1978). Parasite-specified phagocytosis of Chlamydia psittaci and Chlamydia trachomatis by L and HeLa cells. Infect Immun, 19, 598–606
   PubMedGoogle Scholar
• Byrne GI, Ouellette SP, Wang Z, Rao JP, Lu L, Beatty WL, Hudson AP. (2001). Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells. Infect Immun, 69, 5423–5429
   PubMedGoogle Scholar
• Caldwell HD, Kromhout J, Schachter J. (1981). Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun, 31, 1161–1176
   PubMed Web of Science ®Google Scholar
• Campbell LA, Kuo CC. (2004). Chlamydia pneumoniae–an infectious risk factor for atherosclerosis? Nat Rev Microbiol, 2, 23–32
   PubMed Web of Science ®Google Scholar
• Carabeo RA, Hackstadt T. (2001). Isolation and characterization of a mutant Chinese hamster ovary cell line that is resistant to Chlamydia trachomatis infection at a novel step in the attachment process. Infect Immun, 69, 5899–5904
   PubMedGoogle Scholar
• Carabeo RA, Grieshaber SS, Fischer E, Hackstadt T. (2002). Chlamydia trachomatis induces remodeling of the actin cytoskeleton during attachment and entry into HeLa cells. Infect Immun, 70, 3793–3803
   PubMed Web of Science ®Google Scholar
• Castanon JI. (2007). History of the use of antibiotic as growth promoters in European poultry feeds. Poult Sci, 86, 2466–2471
   PubMed Web of Science ®Google Scholar
• Chen X, Schauder S, Potier N, Van Dorsselaer A, Pelczer I, Bassler BL, Hughson FM. (2002). Structural identification of a bacterial quorum-sensing signal containing boron. Nature, 415, 545–549
   PubMed Web of Science ®Google Scholar
• Chiliveru S, Birkelund S, Paludan SR. (2010). Induction of interferon-stimulated genes by Chlamydia pneumoniae in fibroblasts is mediated by intracellular nucleotide-sensing receptors. PLoS ONE, 5, e10005
   Google Scholar
• Chitambar CR, Narasimhan J. (1991). Targeting iron-dependent DNA synthesis with gallium and transferrin-gallium. Pathobiology, 59, 3–10
   PubMed Web of Science ®Google Scholar
• Chopra I, Storey C, Falla TJ, Pearce JH. (1998). Antibiotics, peptidoglycan synthesis and genomics: the chlamydial anomaly revisited. Microbiology (Reading, Engl), 144 (Pt 10), 2673–2678
   PubMedGoogle Scholar
• Cianciotto NP. (2007). Iron acquisition by Legionella pneumophila. Biometals, 20, 323–331
   PubMedGoogle Scholar
• Clarke MB, Hughes DT, Zhu C, Boedeker EC, Sperandio V. (2006). The QseC sensor kinase: a bacterial adrenergic receptor. Proc Natl Acad Sci USA, 103, 10420–10425
   PubMed Web of Science ®Google Scholar
• Clifton DR, Fields KA, Grieshaber SS, Dooley CA, Fischer ER, Mead DJ, Carabeo RA, Hackstadt T. (2004). A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc Natl Acad Sci USA, 101, 10166–10171
   PubMed Web of Science ®Google Scholar
• Coombes BK, Mahony JB. (2002). Identification of MEK- and phosphoinositide 3-kinase-dependent signalling as essential events during Chlamydia pneumoniae invasion of HEp2 cells. Cell Microbiol, 4, 447–460
   PubMedGoogle Scholar
• Cortes C, Rzomp KA, Tvinnereim A, Scidmore MA, Wizel B. (2007). Chlamydia pneumoniae inclusion membrane protein Cpn0585 interacts with multiple Rab GTPases. Infect Immun, 75, 5586–5596
   PubMed Web of Science ®Google Scholar
• Costerton JW, Poffenroth L, Wilt JC, Kordová N. (1976). Ultrastructural studies of the nucleoids of the pleomorphic forms of Chlamydia psittaci 6BC: a comparison with bacteria. Can J Microbiol, 22, 16–28
   PubMedGoogle Scholar
• Cotter TW, Meng Q, Shen ZL, Zhang YX, Su H, Caldwell HD. (1995). Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect Immun, 63, 4704–4714
   PubMed Web of Science ®Google Scholar
• Cotter SE, Surana NK, St Geme JW 3rd. (2005). Trimeric autotransporters: a distinct subfamily of autotransporter proteins. Trends Microbiol, 13, 199–205
   PubMed Web of Science ®Google Scholar
• Crane DD, Carlson JH, Fischer ER, Bavoil P, Hsia RC, Tan C, Kuo CC, Caldwell HD. (2006). Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen. Proc Natl Acad Sci USA, 103, 1894–1899
   PubMed Web of Science ®Google Scholar
• Dautry-Varsat A, Subtil A, Hackstadt T. (2005). Recent insights into the mechanisms of Chlamydia entry. Cell Microbiol, 7, 1714–1722
   PubMedGoogle Scholar
• Davis CH, Wyrick PB. (1997). Differences in the association of Chlamydia trachomatis serovar E and serovar L2 with epithelial cells in vitro may reflect biological differences in vivo. Infect Immun, 65, 2914–2924
   PubMedGoogle Scholar
• Delevoye C, Nilges M, Dehoux P, Paumet F, Perrinet S, Dautry-Varsat A, Subtil A. (2008). SNARE protein mimicry by an intracellular bacterium. PLoS Pathog, 4, e1000022
   PubMed Web of Science ®Google Scholar
• DeMars R, Weinfurter J. (2008). Interstrain gene transfer in Chlamydia trachomatis in vitro: mechanism and significance. J Bacteriol, 190, 1605–1614
   PubMed Web of Science ®Google Scholar
• Demars R, Weinfurter J, Guex E, Lin J, Potucek Y. (2007). Lateral gene transfer in vitro in the intracellular pathogen Chlamydia trachomatis. J Bacteriol, 189, 991–1003
   PubMed Web of Science ®Google Scholar
• Di Francesco A, Donati M, Rossi M, Pignanelli S, Shurdhi A, Baldelli R, Cevenini R. (2008). Tetracycline-resistant Chlamydia suis isolates in Italy. Vet Rec, 163, 251–252
   PubMed Web of Science ®Google Scholar
• Diggle SP, Cornelis P, Williams P, Cámara M. (2006). 4-quinolone signalling in Pseudomonas aeruginosa: old molecules, new perspectives. Int J Med Microbiol, 296, 83–91
   PubMed Web of Science ®Google Scholar
• Dugan J, Rockey DD, Jones L, Andersen AA. (2004). Tetracycline resistance in Chlamydia suis mediated by genomic islands inserted into the chlamydial inv-like gene. Antimicrob Agents Chemother, 48, 3989–3995
   PubMed Web of Science ®Google Scholar
• Dugan J, Andersen AA, Rockey DD. (2007). Functional characterization of IScs605, an insertion element carried by tetracycline-resistant Chlamydia suis. Microbiology (Reading, Engl), 153, 71–79
   PubMedGoogle Scholar
• Eisele NA, Anderson DM. (2009). Dual-function antibodies to Yersinia pestis LcrV required for pulmonary clearance of plague. Clin Vaccine Immunol, 16, 1720–1727
   PubMed Web of Science ®Google Scholar
• Eissenberg LG, Wyrick PB. (1981). Inhibition of phagolysosome fusion is localized to Chlamydia psittaci-laden vacuoles. Infect Immun, 32, 889–896
   PubMed Web of Science ®Google Scholar
• Elwell CA, Ceesay A, Kim JH, Kalman D, Engel JN. (2008). RNA interference screen identifies Abl kinase and PDGFR signaling in Chlamydia trachomatis entry. PLoS Pathog, 4, e1000021
   PubMed Web of Science ®Google Scholar
• Ernst JD. (2000). Bacterial inhibition of phagocytosis. Cell Microbiol, 2, 379–386
   PubMedGoogle Scholar
• Escaich S. (2010). Novel agents to inhibit microbial virulence and pathogenicity. Expert Opin Ther Pat, 20, 1401–1418
   PubMed Web of Science ®Google Scholar
• Escalante-Ochoa C, Ducatelle R, Haesebrouck F. (1998). The intracellular life of Chlamydia psittaci: how do the bacteria interact with the host cell? FEMS Microbiol Rev, 22, 65–78
   PubMedGoogle Scholar
• Everett KD, Hatch TP. (1991). Sequence analysis and lipid modification of the cysteine-rich envelope proteins of Chlamydia psittaci 6BC. J Bacteriol, 173, 3821–3830
   PubMed Web of Science ®Google Scholar
• Everett KD. (2000). Chlamydia and Chlamydiales: more than meets the eye. Vet Microbiol, 75, 109–126
   PubMed Web of Science ®Google Scholar
• Fadel S, Eley A. (2004). Chlorate: a reversible inhibitor of proteoglycan sulphation in Chlamydia trachomatis-infected cells. J Med Microbiol, 53, 93–95
   PubMed Web of Science ®Google Scholar
• Fadel S, Eley A. (2007). Chlamydia trachomatis OmcB protein is a surface-exposed glycosaminoglycan-dependent adhesin. J Med Microbiol, 56, 15–22
   PubMed Web of Science ®Google Scholar
• Fadel S, Eley A. (2008). Differential glycosaminoglycan binding of Chlamydia trachomatis OmcB protein from serovars E and LGV. J Med Microbiol, 57, 1058–1061
   PubMed Web of Science ®Google Scholar
• Finco O, Bonci A, Agnusdei M, Scarselli M, Petracca R, Norais N, Ferrari G, Garaguso I, Donati M, Sambri V, Cevenini R, Ratti G, Grandi G. (2005). Identification of new potential vaccine candidates against Chlamydia pneumoniae by multiple screenings. Vaccine, 23, 1178–1188
   PubMedGoogle Scholar
• Fox A, Rogers JC, Gilbart J, Morgan S, Davis CH, Knight S, Wyrick PB. (1990). Muramic acid is not detectable in Chlamydia psittaci or Chlamydia trachomatis by gas chromatography-mass spectrometry. Infect Immun, 58, 835–837
   PubMed Web of Science ®Google Scholar
• Frank DW, Vallis A, Wiener-Kronish JP, Roy-Burman A, Spack EG, Mullaney BP, Megdoud M, Marks JD, Fritz R, Sawa T. (2002). Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV. J Infect Dis, 186, 64–73
   PubMed Web of Science ®Google Scholar
• Fudyk T, Olinger L, Stephens RS. (2002). Selection of mutant cell lines resistant to infection by Chlamydia spp [corrected]. Infect Immun, 70, 6444–6447
   PubMedGoogle Scholar
• Gébus C, Caroline G, Faudry E, Eric F, Bohn YS, Elsen S, Sylvie E, Attree I. (2008). Oligomerization of PcrV and LcrV, protective antigens of Pseudomonas aeruginosa and Yersinia pestis. J Biol Chem, 283, 23940–23949
   PubMedGoogle Scholar
• Gérard HC, Krausse-Opatz B, Wang Z, Rudy D, Rao JP, Zeidler H, Schumacher HR, Whittum-Hudson JA, Köhler L, Hudson AP. (2001). Expression of Chlamydia trachomatis genes encoding products required for DNA synthesis and cell division during active versus persistent infection. Mol Microbiol, 41, 731–741
   PubMed Web of Science ®Google Scholar
• Gombos I, Kiss E, Detre C, László G, Matkó J. (2006). Cholesterol and sphingolipids as lipid organizers of the immune cells’ plasma membrane: their impact on the functions of MHC molecules, effector T-lymphocytes and T-cell death. Immunol Lett, 104, 59–69
   PubMed Web of Science ®Google Scholar
• Gomez HF, Ochoa TJ, Carlin LG, Cleary TG. (2003). Human lactoferrin impairs virulence of Shigella flexneri. J Infect Dis, 187, 87–95
   PubMed Web of Science ®Google Scholar
• Goure J, Broz P, Attree O, Cornelis GR, Attree I. (2005). Protective anti-V antibodies inhibit Pseudomonas and Yersinia translocon assembly within host membranes. J Infect Dis, 192, 218–225
   PubMed Web of Science ®Google Scholar
• Grieshaber S, Swanson JA, Hackstadt T. (2002). Determination of the physical environment within the Chlamydia trachomatis inclusion using ion-selective ratiometric probes. Cell Microbiol, 4, 273–283
   PubMedGoogle Scholar
• Gump DW. (1996). Antimicrobial susceptibility testing for some atypical microorganisms: chlamydiae, mycoplasmas, rickettsia and spirochetes. Baltimore: Williams & Wilkins
   Google Scholar
• Hackstadt T, Fischer ER, Scidmore MA, Rockey DD, Heinzen RA. (1997). Origins and functions of the chlamydial inclusion. Trends Microbiol, 5, 288–293
   PubMed Web of Science ®Google Scholar
• Hackstadt T, Todd WJ, Caldwell HD. (1985). Disulfide-mediated interactions of the chlamydial major outer membrane protein: role in the differentiation of chlamydiae? J Bacteriol, 161, 25–31
   PubMed Web of Science ®Google Scholar
• Hackstadt T, Rockey DD, Heinzen RA, Scidmore MA. (1996). Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane. EMBO J, 15, 964–977
   PubMed Web of Science ®Google Scholar
• Hackstadt T, Scidmore-Carlson MA, Shaw EI, Fischer ER. (1999). The Chlamydia trachomatis IncA protein is required for homotypic vesicle fusion. Cell Microbiol, 1, 119–130
   PubMedGoogle Scholar
• Harley R, Herring A, Egan K, Howard P, Gruffydd-Jones T, Azuma Y, Shirai M, Helps C. (2007). Molecular characterisation of 12 Chlamydophila felis polymorphic membrane protein genes. Vet Microbiol, 124, 230–238
   PubMedGoogle Scholar
• Hatch TP, Al-Hossainy E, Silverman JA. (1982). Adenine nucleotide and lysine transport in Chlamydia psittaci. J Bacteriol, 150, 662–670
   PubMedGoogle Scholar
• Hatch TP, Allan I, Pearce JH. (1984). Structural and polypeptide differences between envelopes of infective and reproductive life cycle forms of Chlamydia spp. J Bacteriol, 157, 13–20
   PubMed Web of Science ®Google Scholar
• Hatch TP. (1996). Disulfide cross-linked envelope proteins: the functional equivalent of peptidoglycan in chlamydiae? J Bacteriol, 178, 1–5
   PubMed Web of Science ®Google Scholar
• Heinzen RA, Scidmore MA, Rockey DD, Hackstadt T. (1996). Differential interaction with endocytic and exocytic pathways distinguish parasitophorous vacuoles of Coxiella burnetii and Chlamydia trachomatis. Infect Immun, 64, 796–809
   PubMed Web of Science ®Google Scholar
• Heinzen RA, Hackstadt T. (1997). The Chlamydia trachomatis parasitophorous vacuolar membrane is not passively permeable to low-molecular-weight compounds. Infect Immun, 65, 1088–1094
   PubMedGoogle Scholar
• Helms JB, Zurzolo C. (2004). Lipids as targeting signals: lipid rafts and intracellular trafficking. Traffic, 5, 247–254
   PubMed Web of Science ®Google Scholar
• Henderson IR, Lam AC. (2001). Polymorphic proteins of Chlamydia spp.–autotransporters beyond the Proteobacteria. Trends Microbiol, 9, 573–578
   PubMed Web of Science ®Google Scholar
• Henke JM, Bassler BL. (2004). Three parallel quorum-sensing systems regulate gene expression in Vibrio harveyi. J Bacteriol, 186, 6902–6914
   PubMed Web of Science ®Google Scholar
• Hentzer M, Wu H, Andersen JB, Riedel K, Rasmussen TB, Bagge N, Kumar N, Schembri MA, Song Z, Kristoffersen P, Manefield M, Costerton JW, Molin S, Eberl L, Steinberg P, Kjelleberg S, Høiby N, Givskov M. (2003). Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J, 22, 3803–3815
   PubMed Web of Science ®Google Scholar
• Higgins DA, Pomianek ME, Kraml CM, Taylor RK, Semmelhack MF, Bassler BL. (2007). The major Vibrio cholerae autoinducer and its role in virulence factor production. Nature, 450, 883–886
   PubMed Web of Science ®Google Scholar
• Hodinka RL, Davis CH, Choong J, Wyrick PB. (1988). Ultrastructural study of endocytosis of Chlamydia trachomatis by McCoy cells. Infect Immun, 56, 1456–1463
   PubMedGoogle Scholar
• Hogan RJ, Mathews SA, Mukhopadhyay S, Summersgill JT, Timms P. (2004). Chlamydial persistence: beyond the biphasic paradigm. Infect Immun, 72, 1843–1855
   PubMed Web of Science ®Google Scholar
• Hughes DT, Sperandio V. (2008). Inter-kingdom signalling: communication between bacteria and their hosts. Nat Rev Microbiol, 6, 111–120
   PubMed Web of Science ®Google Scholar
• Hybiske K, Stephens RS. (2007). Mechanisms of Chlamydia trachomatis entry into nonphagocytic cells. Infect Immun, 75, 3925–3934
   PubMedGoogle Scholar
• Iliffe-Lee ER, McClarty G. (1999). Glucose metabolism in Chlamydia trachomatis: the ‘energy parasite’ hypothesis revisited. Mol Microbiol, 33, 177–187
   PubMed Web of Science ®Google Scholar
• Jewett TJ, Fischer ER, Mead DJ, Hackstadt T. (2006). Chlamydial TARP is a bacterial nucleator of actin. Proc Natl Acad Sci USA, 103, 15599–15604
   PubMed Web of Science ®Google Scholar
• Johnson FW, Spencer WN. (1983). Multiantibiotic resistance in Chlamydia psittaci from ducks. Vet Rec, 112, 208
   PubMed Web of Science ®Google Scholar
• Jones RB, Van der Pol B, Martin DH, Shepard MK. (1990). Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics. J Infect Dis, 162, 1309–1315
   PubMed Web of Science ®Google Scholar
• Kalman S, Mitchell W, Marathe R, Lammel C, Fan J, Hyman RW, Olinger L, Grimwood J, Davis RW, Stephens RS. (1999). Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat Genet, 21, 385–389
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Thoendel M, Olakanmi O, Britigan BE, Singh PK. (2007). The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. J Clin Invest, 117, 877–888
   PubMed Web of Science ®Google Scholar
• Kauppi AM, Nordfelth R, Uvell H, Wolf-Watz H, Elofsson M. (2003). Targeting bacterial virulence: inhibitors of type III secretion in Yersinia. Chem Biol, 10, 241–249
   PubMed Web of Science ®Google Scholar
• Kendall MM, Rasko DA, Sperandio V. (2007). Global effects of the cell-to-cell signaling molecules autoinducer-2, autoinducer-3, and epinephrine in a luxS mutant of enterohemorrhagic Escherichia coli. Infect Immun, 75, 4875–4884
   PubMed Web of Science ®Google Scholar
• Keyser P, Elofsson M, Rosell S, Wolf-Watz H. (2008). Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria. J Intern Med, 264, 17–29
   PubMed Web of Science ®Google Scholar
• Kim SK, DeMars R. (2001). Epitope clusters in the major outer membrane protein of Chlamydia trachomatis. Curr Opin Immunol, 13, 429–436
   PubMed Web of Science ®Google Scholar
• Klingenberg M. (1989). Molecular aspects of the adenine nucleotide carrier from mitochondria. Arch Biochem Biophys, 270, 1–14
   PubMedGoogle Scholar
• Koo IC, Stephens RS. (2003). A developmentally regulated two-component signal transduction system in Chlamydia. J Biol Chem, 278, 17314–17319
   PubMedGoogle Scholar
• Lane BJ, Mutchler C, Al Khodor S, Grieshaber SS, Carabeo RA. (2008). Chlamydial entry involves TARP binding of guanine nucleotide exchange factors. PLoS Pathog, 4, e1000014
   PubMedGoogle Scholar
• Lefèvre JC, Lépargneur JP. (1998). Comparative in vitro susceptibility of a tetracycline-resistant Chlamydia trachomatis strain isolated in Toulouse (France). Sex Transm Dis, 25, 350–352
   PubMed Web of Science ®Google Scholar
• Lillemeier BF, Pfeiffer JR, Surviladze Z, Wilson BS, Davis MM. (2006). Plasma membrane-associated proteins are clustered into islands attached to the cytoskeleton. Proc Natl Acad Sci USA, 103, 18992–18997
   PubMed Web of Science ®Google Scholar
• Linington RG, Robertson M, Gauthier A, Finlay BB, van Soest R, Andersen RJ. (2002). Caminoside A, an antimicrobial glycolipid isolated from the marine sponge Caminus sphaeroconia. Org Lett, 4, 4089–4092
   PubMed Web of Science ®Google Scholar
• Linington RG, Robertson M, Gauthier A, Finlay BB, MacMillan JB, Molinski TF, van Soest R, Andersen RJ. (2006). Caminosides B-D, antimicrobial glycolipids isolated from the marine sponge Caminus sphaeroconia. J Nat Prod, 69, 173–177
   PubMed Web of Science ®Google Scholar
• Linka N, Hurka H, Lang BF, Burger G, Winkler HH, Stamme C, Urbany C, Seil I, Kusch J, Neuhaus HE. (2003). Phylogenetic relationships of non-mitochondrial nucleotide transport proteins in bacteria and eukaryotes. Gene, 306, 27–35
   PubMed Web of Science ®Google Scholar
• Litwin J, Officer JE, Brown A, Moulder JW. (1961). A comparative study of the growth cycles of different members of the psittacosis group in different host cells. J Infect Dis, 109, 251–279
   PubMedGoogle Scholar
• Liu X, Afrane M, Clemmer DE, Zhong G, Nelson DE. (2010). Identification of Chlamydia trachomatis outer membrane complex proteins by differential proteomics. J Bacteriol, 192, 2852–2860
   PubMed Web of Science ®Google Scholar
• Longbottom D, Russell M, Jones GE, Lainson FA, Herring AJ. (1996). Identification of a multigene family coding for the 90 kDa proteins of the ovine abortion subtype of Chlamydia psittaci. FEMS Microbiol Lett, 142, 277–281
   PubMed Web of Science ®Google Scholar
• Longbottom D, Coulter LJ. (2003). Animal chlamydioses and zoonotic implications. J Comp Pathol, 128, 217–244
   PubMed Web of Science ®Google Scholar
• Lyon GJ, Novick RP. (2004). Peptide signaling in Staphylococcus aureus and other Gram-positive bacteria. Peptides, 25, 1389–1403
   PubMed Web of Science ®Google Scholar
• Markham AP, Barrett BS, Esfandiary R, Picking WL, Picking WD, Joshi SB, Middaugh CR. (2010). Formulation and immunogenicity of a potential multivalent type III secretion system-based protein vaccine. J Pharm Sci, 99, 4497–4509
   PubMedGoogle Scholar
• Mathews S, George C, Flegg C, Stenzel D, Timms P. (2001). Differential expression of ompA, ompB, pyk, nlpD and Cpn0585 genes between normal and interferon-gamma treated cultures of Chlamydia pneumoniae. Microb Pathog, 30, 337–345
   PubMedGoogle Scholar
• Matsumoto A, Fujiwara E, Higashi N. (1976). Observations of the surface projections of infectious small cell of Chlamydia psittaci in thin sections. J Electron Microsc (Tokyo), 25, 169–170
   PubMedGoogle Scholar
• Matsumoto A. (1982a). Electron microscopic observations of surface projections on Chlamydia psittaci reticulate bodies. J Bacteriol, 150, 358–364
   PubMedGoogle Scholar
• Matsumoto A. (1982b). Surface projections of Chlamydia psittaci elementary bodies as revealed by freeze-deep-etching. J Bacteriol, 151, 1040–1042
   PubMedGoogle Scholar
• McCoy AJ, Maurelli AT. (2006). Building the invisible wall: updating the chlamydial peptidoglycan anomaly. Trends Microbiol, 14, 70–77
   PubMedGoogle Scholar
• McDowell P, Affas Z, Reynolds C, Holden MT, Wood SJ, Saint S, Cockayne A, Hill PJ, Dodd CE, Bycroft BW, Chan WC, Williams P. (2001). Structure, activity and evolution of the group I thiolactone peptide quorum-sensing system of Staphylococcus aureus. Mol Microbiol, 41, 503–512
   PubMed Web of Science ®Google Scholar
• Misyurina OY, Chipitsyna EV, Finashutina YP, Lazarev VN, Akopian TA, Savicheva AM, Govorun VM. (2004). Mutations in a 23S rRNA gene of Chlamydia trachomatis associated with resistance to macrolides. Antimicrob Agents Chemother, 48, 1347–1349
   PubMed Web of Science ®Google Scholar
• Moelleken K, Hegemann JH. (2008). The Chlamydia outer membrane protein OmcB is required for adhesion and exhibits biovar-specific differences in glycosaminoglycan binding. Mol Microbiol, 67, 403–419
   PubMed Web of Science ®Google Scholar
• Moulder JW. (1991). Interaction of chlamydiae and host cells in vitro. Microbiol Rev, 55, 143–190
   PubMedGoogle Scholar
• Moulder JW. (1993). Why is Chlamydia sensitive to penicillin in the absence of peptidoglycan? Infect Agents Dis, 2, 87–99
   PubMedGoogle Scholar
• Moulin G, Cavalié P, Pellanne I, Chevance A, Laval A, Millemann Y, Colin P, Chauvin C; Antimicrobial Resistance ad hoc Group of the French Food Safety Agency. (2008). A comparison of antimicrobial usage in human and veterinary medicine in France from 1999 to 2005. J Antimicrob Chemother, 62, 617–625
   PubMed Web of Science ®Google Scholar
• Mpiga P, Ravaoarinoro M. (2006). Chlamydia trachomatis persistence: an update. Microbiol Res, 161, 9–19
   PubMed Web of Science ®Google Scholar
• Mueller CA, Broz P, Cornelis GR. (2008). The type III secretion system tip complex and translocon. Mol Microbiol, 68, 1085–1095
   PubMed Web of Science ®Google Scholar
• Muschiol S, Bailey L, Gylfe A, Sundin C, Hultenby K, Bergström S, Elofsson M, Wolf-Watz H, Normark S, Henriques-Normark B. (2006). A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis. Proc Natl Acad Sci USA, 103, 14566–14571
   PubMed Web of Science ®Google Scholar
• Muschiol S, Normark S, Henriques-Normark B, Subtil A. (2009). Small molecule inhibitors of the Yersinia type III secretion system impair the development of Chlamydia after entry into host cells. BMC Microbiol, 9, 75
   PubMed Web of Science ®Google Scholar
• Newhall WJ, Jones RB. (1983). Disulfide-linked oligomers of the major outer membrane protein of chlamydiae. J Bacteriol, 154, 998–1001
   PubMed Web of Science ®Google Scholar
• Newhall WJ 5th. (1987). Biosynthesis and disulfide cross-linking of outer membrane components during the growth cycle of Chlamydia trachomatis. Infect Immun, 55, 162–168
   PubMed Web of Science ®Google Scholar
• Novick RP. (2003). Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol, 48, 1429–1449
   PubMed Web of Science ®Google Scholar
• Ochoa TJ, Noguera-Obenza M, Ebel F, Guzman CA, Gomez HF, Cleary TG. (2003). Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli. Infect Immun, 71, 5149–5155
   PubMedGoogle Scholar
• Ochoa TJ, Clearly TG. (2004). Lactoferrin disruption of bacterial type III secretion systems. Biometals, 17, 257–260
   PubMedGoogle Scholar
• Pan J, Ren D. (2009). Quorum sensing inhibitors: a patent overview. Expert Opin Ther Pat, 19, 1581–1601
   PubMed Web of Science ®Google Scholar
• Paradkar PN, De Domenico I, Durchfort N, Zohn I, Kaplan J, Ward DM. (2008). Iron depletion limits intracellular bacterial growth in macrophages. Blood, 112, 866–874
   PubMedGoogle Scholar
• Parton RG, Richards AA. (2003). Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms. Traffic, 4, 724–738
   PubMed Web of Science ®Google Scholar
• Peeling R, Maclean IW, Brunham RC. (1984). In vitro neutralization of Chlamydia trachomatis with monoclonal antibody to an epitope on the major outer membrane protein. Infect Immun, 46, 484–488
   PubMed Web of Science ®Google Scholar
• Peters J, Wilson DP, Myers G, Timms P, Bavoil PM. (2007). Type III secretion à la Chlamydia. Trends Microbiol, 15, 241–251
   PubMed Web of Science ®Google Scholar
• Peterson EM, Cheng X, Markoff BA, Fielder TJ, de la Maza LM. (1991). Functional and structural mapping of Chlamydia trachomatis species-specific major outer membrane protein epitopes by use of neutralizing monoclonal antibodies. Infect Immun, 59, 4147–4153
   PubMed Web of Science ®Google Scholar
• Peterson JR, Mitchison TJ. (2002). Small molecules, big impact: a history of chemical inhibitors and the cytoskeleton. Chem Biol, 9, 1275–1285
   PubMed Web of Science ®Google Scholar
• Philipovskiy AV, Cowan C, Wulff-Strobel CR, Burnett SH, Kerschen EJ, Cohen DA, Kaplan AM, Straley SC. (2005). Antibody against V antigen prevents Yop-dependent growth of Yersinia pestis. Infect Immun, 73, 1532–1542
   PubMed Web of Science ®Google Scholar
• Prain CJ, Pearce JH. (1989). Ultrastructural studies on the intracellular fate of Chlamydia psittaci (strain guinea pig inclusion conjunctivitis) and Chlamydia trachomatis (strain lymphogranuloma venereum 434): modulation of intracellular events and relationship with endocytic mechanism. J Gen Microbiol, 135, 2107–2123
   PubMedGoogle Scholar
• Prantner D, Nagarajan UM. (2009). Role for the chlamydial type III secretion apparatus in host cytokine expression. Infect Immun, 77, 76–84
   PubMedGoogle Scholar
• Rasko DA, Moreira CG, Li de R, Reading NC, Ritchie JM, Waldor MK, Williams N, Taussig R, Wei S, Roth M, Hughes DT, Huntley JF, Fina MW, Falck JR, Sperandio V. (2008). Targeting QseC signaling and virulence for antibiotic development. Science, 321, 1078–1080
   PubMed Web of Science ®Google Scholar
• Rasko DA, Sperandio V. (2010). Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov, 9, 117–128
   PubMed Web of Science ®Google Scholar
• Rasmussen-Lathrop SJ, Koshiyama K, Phillips N, Stephens RS. (2000). Chlamydia-dependent biosynthesis of a heparan sulphate-like compound in eukaryotic cells. Cell Microbiol, 2, 137–144
   PubMedGoogle Scholar
• Rasmussen TB, Bjarnsholt T, Skindersoe ME, Hentzer M, Kristoffersen P, Köte M, Nielsen J, Eberl L, Givskov M. (2005a). Screening for quorum-sensing inhibitors (QSI) by use of a novel genetic system, the QSI selector. J Bacteriol, 187, 1799–1814
   PubMed Web of Science ®Google Scholar
• Rasmussen TB, Skindersoe ME, Bjarnsholt T, Phipps RK, Christensen KB, Jensen PO, Andersen JB, Koch B, Larsen TO, Hentzer M, Eberl L, Hoiby N, Givskov M. (2005b). Identity and effects of quorum-sensing inhibitors produced by Penicillium species. Microbiology (Reading, Engl), 151, 1325–1340
   PubMed Web of Science ®Google Scholar
• Raulston JE, Davis CH, Schmiel DH, Morgan MW, Wyrick PB. (1993). Molecular characterization and outer membrane association of a Chlamydia trachomatis protein related to the hsp70 family of proteins. J Biol Chem, 268, 23139–23147
   PubMedGoogle Scholar
• Raulston JE. (1997). Response of Chlamydia trachomatis serovar E to iron restriction in vitro and evidence for iron-regulated chlamydial proteins. Infect Immun, 65, 4539–4547
   PubMed Web of Science ®Google Scholar
• Ravn L, Christensen AB, Molin S, Givskov M, Gram L. (2001). Methods for detecting acylated homoserine lactones produced by Gram-negative bacteria and their application in studies of AHL-production kinetics. J Microbiol Methods, 44, 239–251
   PubMed Web of Science ®Google Scholar
• Read TD, Myers GS, Brunham RC, Nelson WC, Paulsen IT, Heidelberg J, Holtzapple E, Khouri H, Federova NB, Carty HA, Umayam LA, Haft DH, Peterson J, Beanan MJ, White O, Salzberg SL, Hsia RC, McClarty G, Rank RG, Bavoil PM, Fraser CM. (2003). Genome sequence of Chlamydophila caviae (Chlamydia psittaci GPIC): examining the role of niche-specific genes in the evolution of the Chlamydiaceae. Nucleic Acids Res, 31, 2134–2147
   PubMed Web of Science ®Google Scholar
• Ren Q, Kang KH, Paulsen IT. (2004). TransportDB: a relational database of cellular membrane transport systems. Nucleic Acids Res, 32, D284–D288
   Google Scholar
• Reynolds DJ, Pearce JH. (1990). Characterization of the cytochalasin D-resistant (pinocytic) mechanisms of endocytosis utilized by chlamydiae. Infect Immun, 58, 3208–3216
   PubMedGoogle Scholar
• Ridderhof JC, Barnes RC. (1989). Fusion of inclusions following superinfection of HeLa cells by two serovars of Chlamydia trachomatis. Infect Immun, 57, 3189–3193
   PubMedGoogle Scholar
• Rockey DD, Fischer ER, Hackstadt T. (1996). Temporal analysis of the developing Chlamydia psittaci inclusion by use of fluorescence and electron microscopy. Infect Immun, 64, 4269–4278
   PubMedGoogle Scholar
• Rockey DD, Matsumoto A. (2000). The chlamydial developmental cycle. Washington DC: ASM Press
   Google Scholar
• Rockey DD, Scidmore MA, Bannantine JP, Brown WJ. (2002). Proteins in the chlamydial inclusion membrane. Microbes Infect, 4, 333–340
   PubMedGoogle Scholar
• Rzomp KA, Moorhead AR, Scidmore MA. (2006). The GTPase Rab4 interacts with Chlamydia trachomatis inclusion membrane protein CT229. Infect Immun, 74, 5362–5373
   PubMed Web of Science ®Google Scholar
• Saier MH Jr. (2000). A functional-phylogenetic classification system for transmembrane solute transporters. Microbiol Mol Biol Rev, 64, 354–411
   PubMed Web of Science ®Google Scholar
• Salmond GP, Bycroft BW, Stewart GS, Williams P. (1995). The bacterial ‘enigma’: cracking the code of cell-cell communication. Mol Microbiol, 16, 615–624
   PubMed Web of Science ®Google Scholar
• Sanchez-Campillo M, Bini L, Comanducci M, Raggiaschi R, Marzocchi B, Pallini V, Ratti G. (1999). Identification of immunoreactive proteins of Chlamydia trachomatis by Western blot analysis of a two-dimensional electrophoresis map with patient sera. Electrophoresis, 20, 2269–2279
   PubMed Web of Science ®Google Scholar
• Sandoz KM, Rockey DD. (2010). Antibiotic resistance in Chlamydiae. Future Microbiol, 5, 1427–1442
   PubMed Web of Science ®Google Scholar
• Sardinia LM, Segal E, Ganem D. (1988). Developmental regulation of the cysteine-rich outer-membrane proteins of murine Chlamydia trachomatis. J Gen Microbiol, 134, 997–1004
   PubMedGoogle Scholar
• Sarmah AK, Meyer MT, Boxall AB. (2006). A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment. Chemosphere, 65, 725–759
   PubMed Web of Science ®Google Scholar
• Schauder S, Shokat K, Surette MG, Bassler BL. (2001). The LuxS family of bacterial autoinducers: biosynthesis of a novel quorum-sensing signal molecule. Mol Microbiol, 41, 463–476
   PubMed Web of Science ®Google Scholar
• Schautteet K, De Clercq E, Miry C, Van Groenweghe F, Delava P, Kalmar I, Vanrompay D. (2012). Chlamydia suis and reproductive failure in Belgian, Cypriote, German and Israeli pigs. Journal of Medical Microbiology (in press)
   Google Scholar
• Schramm N, Bagnell CR, Wyrick PB. (1996). Vesicles containing Chlamydia trachomatis serovar L2 remain above pH 6 within HEC-1B cells. Infect Immun, 64, 1208–1214
   PubMedGoogle Scholar
• Schwarzenbacher R, Stenner-Liewen F, Liewen H, Robinson H, Yuan H, Bossy-Wetzel E, Reed JC, Liddington RC. (2004). Structure of the Chlamydia protein CADD reveals a redox enzyme that modulates host cell apoptosis. J Biol Chem, 279, 29320–29324
   PubMedGoogle Scholar
• Scidmore MA, Fischer ER, Hackstadt T. (1996). Sphingolipids and glycoproteins are differentially trafficked to the Chlamydia trachomatis inclusion. J Cell Biol, 134, 363–374
   PubMed Web of Science ®Google Scholar
• Scidmore MA, Fischer ER, Hackstadt T. (2003). Restricted fusion of Chlamydia trachomatis vesicles with endocytic compartments during the initial stages of infection. Infect Immun, 71, 973–984
   PubMed Web of Science ®Google Scholar
• Shaw EI, Dooley CA, Fischer ER, Scidmore MA, Fields KA, Hackstadt T. (2000). Three temporal classes of gene expression during the Chlamydia trachomatis developmental cycle. Mol Microbiol, 37, 913–925
   PubMed Web of Science ®Google Scholar
• Simons K, Toomre D. (2000). Lipid rafts and signal transduction. Nat Rev Mol Cell Biol, 1, 31–39
   PubMed Web of Science ®Google Scholar
• Skoudy A, Mounier J, Aruffo A, Ohayon H, Gounon P, Sansonetti P, Tran Van Nhieu G. (2000). CD44 binds to the Shigella IpaB protein and participates in bacterial invasion of epithelial cells. Cell Microbiol, 2, 19–33
   PubMedGoogle Scholar
• Slepenkin A, Enquist PA, Hägglund U, de la Maza LM, Elofsson M, Peterson EM. (2007). Reversal of the antichlamydial activity of putative type III secretion inhibitors by iron. Infect Immun, 75, 3478–3489
   PubMed Web of Science ®Google Scholar
• Smith KM, Bu Y, Suga H. (2003a). Induction and inhibition of Pseudomonas aeruginosa quorum sensing by synthetic autoinducer analogs. Chem Biol, 10, 81–89
   PubMed Web of Science ®Google Scholar
• Smith KM, Bu Y, Suga H. (2003b). Library screening for synthetic agonists and antagonists of a Pseudomonas aeruginosa autoinducer. Chem Biol, 10, 563–571
   PubMed Web of Science ®Google Scholar
• Sperandio V, Torres AG, Jarvis B, Nataro JP, Kaper JB. (2003). Bacteria-host communication: the language of hormones. Proc Natl Acad Sci USA, 100, 8951–8956
   PubMed Web of Science ®Google Scholar
• Stenner-Liewen F, Liewen H, Zapata JM, Pawlowski K, Godzik A, Reed JC. (2002). CADD, a Chlamydia protein that interacts with death receptors. J Biol Chem, 277, 9633–9636
   PubMedGoogle Scholar
• Stephens RS, Kalman S, Lammel C, Fan J, Marathe R, Aravind L, Mitchell W, Olinger L, Tatusov RL, Zhao Q, Koonin EV, Davis RW. (1998). Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science, 282, 754–759
   PubMed Web of Science ®Google Scholar
• Stephens RS, Koshiyama K, Lewis E, Kubo A. (2001). Heparin-binding outer membrane protein of chlamydiae. Mol Microbiol, 40, 691–699
   PubMed Web of Science ®Google Scholar
• Stephens RS, Lammel CJ. (2001). Chlamydia outer membrane protein discovery using genomics. Curr Opin Microbiol, 4, 16–20
   PubMed Web of Science ®Google Scholar
• Stuart ES, Webley WC, Norkin LC. (2003). Lipid rafts, caveolae, caveolin-1, and entry by Chlamydiae into host cells. Exp Cell Res, 287, 67–78
   PubMed Web of Science ®Google Scholar
• Su H, Watkins NG, Zhang YX, Caldwell HD. (1990). Chlamydia trachomatis-host cell interactions: role of the chlamydial major outer membrane protein as an adhesin. Infect Immun, 58, 1017–1025
   PubMed Web of Science ®Google Scholar
• Su H, Raymond L, Rockey DD, Fischer E, Hackstadt T, Caldwell HD. (1996). A recombinant Chlamydia trachomatis major outer membrane protein binds to heparan sulfate receptors on epithelial cells. Proc Natl Acad Sci USA, 93, 11143–11148
   PubMed Web of Science ®Google Scholar
• Subtil A, Wyplosz B, Balañá ME, Dautry-Varsat A. (2004). Analysis of Chlamydia caviae entry sites and involvement of Cdc42 and Rac activity. J Cell Sci, 117, 3923–3933
   PubMed Web of Science ®Google Scholar
• Suchland RJ, Sandoz KM, Jeffrey BM, Stamm WE, Rockey DD. (2009). Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro. Antimicrob Agents Chemother, 53, 4604–4611
   PubMed Web of Science ®Google Scholar
• Suga H, Smith KM. (2003). Molecular mechanisms of bacterial quorum sensing as a new drug target. Curr Opin Chem Biol, 7, 586–591
   PubMed Web of Science ®Google Scholar
• Surette MG, Miller MB, Bassler BL. (1999). Quorum sensing in Escherichia coli, Salmonella typhimurium, and Vibrio harveyi: a new family of genes responsible for autoinducer production. Proc Natl Acad Sci USA, 96, 1639–1644
   PubMed Web of Science ®Google Scholar
• Swanson KA, Crane DD, Caldwell HD. (2007). Chlamydia trachomatis species-specific induction of ezrin tyrosine phosphorylation functions in pathogen entry. Infect Immun, 75, 5669–5677
   PubMedGoogle Scholar
• Taraska T, Ward DM, Ajioka RS, Wyrick PB, Davis-Kaplan SR, Davis CH, Kaplan J. (1996). The late chlamydial inclusion membrane is not derived from the endocytic pathway and is relatively deficient in host proteins. Infect Immun, 64, 3713–3727
   PubMed Web of Science ®Google Scholar
• Thomson NR, Yeats C, Bell K, Holden MT, Bentley SD, Livingstone M, Cerdeño-Tárraga AM, Harris B, Doggett J, Ormond D, Mungall K, Clarke K, Feltwell T, Hance Z, Sanders M, Quail MA, Price C, Barrell BG, Parkhill J, Longbottom D. (2005). The Chlamydophila abortus genome sequence reveals an array of variable proteins that contribute to interspecies variation. Genome Res, 15, 629–640
   PubMed Web of Science ®Google Scholar
• Ting LM, Hsia RC, Haidaris CG, Bavoil PM. (1995). Interaction of outer envelope proteins of Chlamydia psittaci GPIC with the HeLa cell surface. Infect Immun, 63, 3600–3608
   PubMed Web of Science ®Google Scholar
• Tjaden J, Winkler HH, Schwöppe C, Van Der Laan M, Möhlmann T, Neuhaus HE. (1999). Two nucleotide transport proteins in Chlamydia trachomatis, one for net nucleoside triphosphate uptake and the other for transport of energy. J Bacteriol, 181, 1196–1202
   PubMed Web of Science ®Google Scholar
• Van Blarcom TJ, Sofer-Podesta C, Ang J, Boyer JL, Crystal RG, Georgiou G. (2010). Affinity maturation of an anti-V antigen IgG expressed in situ through adenovirus gene delivery confers enhanced protection against Yersinia pestis challenge. Gene Ther, 17, 913–921
   PubMedGoogle Scholar
• Van Droogenbroeck C, Beeckman DS, Harkinezhad T, Cox E, Vanrompay D. (2008). Evaluation of the prophylactic use of ovotransferrin against chlamydiosis in SPF turkeys. Vet Microbiol, 132, 372–378
   PubMedGoogle Scholar
• Van Droogenbroeck C, Dossche L, Wauman T, Van Lent S, Phan TT, Beeckman DS, Vanrompay D. (2011). Use of ovotransferrin as an antimicrobial in turkeys naturally infected with Chlamydia psittaci, avian metapneumovirus and Ornithobacterium rhinotracheale. Vet Microbiol, 153, 257–263
   PubMedGoogle Scholar
• Vanrompay D, Charlier G, Ducatelle R, Haesebrouck F. (1996). Ultrastructural changes in avian Chlamydia psittaci serovar A-, B-, and D-infected Buffalo Green Monkey cells. Infect Immun, 64, 1265–1271
   PubMedGoogle Scholar
• Vanrompay D, Mast J, Ducatelle R, Haesebrouck F, Goddeeris B. (1995). Chlamydia psittaci in turkeys: pathogenesis of infections in avian serovars A, B and D. Vet Microbiol, 47, 245–256
   PubMedGoogle Scholar
• Wang J, Chen L, Chen F, Zhang X, Zhang Y, Baseman J, Perdue S, Yeh IT, Shain R, Holland M, Bailey R, Mabey D, Yu P, Zhong G. (2009). A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice. Vaccine, 27, 2967–2980
   PubMed Web of Science ®Google Scholar
• Wang D, Zetterström CE, Gabrielsen M, Beckham KS, Tree JJ, Macdonald SE, Byron O, Mitchell TJ, Gally DL, Herzyk P, Mahajan A, Uvell H, Burchmore R, Smith BO, Elofsson M, Roe AJ. (2011). Identification of bacterial target proteins for the salicylidene acylhydrazide class of virulence-blocking compounds. J Biol Chem, 286, 29922–29931
   PubMed Web of Science ®Google Scholar
• Ward ME. (1988). The Chlamydial developmental cycle. In: Barron AL, ed. Microbiology of Chlamydia. Boca Raton: CRC Press, Inc
   Google Scholar
• Warrell RP Jr, Bockman RS. (1989). Gallium in the treatment of hypercalcemia and bone metastasis. Important Adv Oncol, 1989, 205–220
   PubMedGoogle Scholar
• Watarai M, Funato S, Sasakawa C. (1996). Interaction of Ipa proteins of Shigella flexneri with α5β1 integrin promotes entry of the bacteria into mammalian cells. J Exp Med, 183, 991–999
   PubMed Web of Science ®Google Scholar
• Wehrl W, Brinkmann V, Jungblut PR, Meyer TF, Szczepek AJ. (2004). From the inside out–processing of the Chlamydial autotransporter PmpD and its role in bacterial adhesion and activation of human host cells. Mol Microbiol, 51, 319–334
   PubMed Web of Science ®Google Scholar
• Wilson DP, Timms P, McElwain DL, Bavoil PM. (2006). Type III secretion, contact-dependent model for the intracellular development of chlamydia. Bull Math Biol, 68, 161–178
   PubMed Web of Science ®Google Scholar
• Winkler HH, Neuhaus HE. (1999). Non-mitochondrial ATP transport. Trends Biochem Sci, 24, 64–68
   PubMed Web of Science ®Google Scholar
• Wolf K, Betts HJ, Chellas-Géry B, Hower S, Linton CN, Fields KA. (2006). Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle. Mol Microbiol, 61, 1543–1555
   PubMed Web of Science ®Google Scholar
• Wyrick PB, Choong J, Davis CH, Knight ST, Royal MO, Maslow AS, Bagnell CR. (1989). Entry of genital Chlamydia trachomatis into polarized human epithelial cells. Infect Immun, 57, 2378–2389
   PubMedGoogle Scholar
• Wyrick PB. (2000). Intracellular survival by Chlamydia. Cell Microbiol, 2, 275–282
   PubMed Web of Science ®Google Scholar
• Yekta MA, Verdonck F, Van Den Broeck W, Goddeeris BM, Cox E, Vanrompay D. (2010). Lactoferrin inhibits E. coli O157:H7 growth and attachment to intestinal epithelial cells. Vet Med, 55, 359–368
   Google Scholar
• Yuan Y, Zhang YX, Watkins NG, Caldwell HD. (1989). Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars. Infect Immun, 57, 1040–1049
   PubMed Web of Science ®Google Scholar
• Zavil’gel’skii GB, Manukhov IV. (2001). [“Quorum sensing”, or how bacteria “talk” to each other]. Mol Biol (Mosk), 35, 268–277
   PubMedGoogle Scholar
• Zhang JP, Stephens RS. (1992). Mechanism of C. trachomatis attachment to eukaryotic host cells. Cell, 69, 861–869
   PubMed Web of Science ®Google Scholar